Nothing Special   »   [go: up one dir, main page]

NO20054100D0 - Fremgangsmate for fremstilling av syreaddisjonssalter - Google Patents

Fremgangsmate for fremstilling av syreaddisjonssalter

Info

Publication number
NO20054100D0
NO20054100D0 NO20054100A NO20054100A NO20054100D0 NO 20054100 D0 NO20054100 D0 NO 20054100D0 NO 20054100 A NO20054100 A NO 20054100A NO 20054100 A NO20054100 A NO 20054100A NO 20054100 D0 NO20054100 D0 NO 20054100D0
Authority
NO
Norway
Prior art keywords
acid addition
basic compound
preparation
addition salts
polyacidic
Prior art date
Application number
NO20054100A
Other languages
English (en)
Other versions
NO331272B1 (no
NO20054100L (no
Inventor
Kimiyuki Shibuya
Tadaaki Ohgiya
Takayuki Matsuda
Original Assignee
Kowa Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co filed Critical Kowa Co
Publication of NO20054100D0 publication Critical patent/NO20054100D0/no
Publication of NO20054100L publication Critical patent/NO20054100L/no
Publication of NO331272B1 publication Critical patent/NO331272B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20054100A 2003-02-28 2005-09-02 Syreaddisjonssalter av polysure basiske forbindelser samt fremgangsmate for fremstilling derav NO331272B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003052700 2003-02-28
PCT/JP2004/002375 WO2004076441A1 (ja) 2003-02-28 2004-02-27 多酸性塩基化合物の酸付加塩の製造方法

Publications (3)

Publication Number Publication Date
NO20054100D0 true NO20054100D0 (no) 2005-09-02
NO20054100L NO20054100L (no) 2005-09-22
NO331272B1 NO331272B1 (no) 2011-11-14

Family

ID=32923406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054100A NO331272B1 (no) 2003-02-28 2005-09-02 Syreaddisjonssalter av polysure basiske forbindelser samt fremgangsmate for fremstilling derav

Country Status (21)

Country Link
US (2) US7750150B2 (no)
EP (1) EP1598346B1 (no)
JP (2) JP4594863B2 (no)
KR (1) KR101106127B1 (no)
CN (2) CN1753886B (no)
AT (1) ATE554083T1 (no)
AU (1) AU2004215523B2 (no)
BR (1) BRPI0407908A (no)
CA (1) CA2516822C (no)
DK (1) DK1598346T3 (no)
EA (1) EA009045B1 (no)
ES (1) ES2384517T3 (no)
IL (1) IL170093A (no)
IS (1) IS7978A (no)
MX (1) MXPA05009129A (no)
MY (1) MY140618A (no)
NO (1) NO331272B1 (no)
NZ (1) NZ541716A (no)
PL (1) PL378292A1 (no)
TW (2) TWI374136B (no)
WO (1) WO2004076441A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140849A (en) * 2003-07-07 2010-01-29 Kowa Co 2, 4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
CA2535920C (en) 2003-08-29 2009-06-23 Kowa Co., Ltd. Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
BRPI0614974A2 (pt) * 2005-08-30 2010-12-14 Asahi Kasei Pharma Corp composto, medicamento, inibidor da fosforilaÇço da cadeia leve regulatària da miosina, inibidor da via rho/rho quinase, e, mÉtodo para tratamento terapÊutico e/ou profilÁtico de glaucoma
US8415372B2 (en) 2007-02-27 2013-04-09 Asahi Kasei Pharma Corporation Sulfonamide compound
CN101622243B (zh) 2007-02-28 2013-12-04 旭化成制药株式会社 磺酰胺衍生物
AU2008272396B2 (en) 2007-07-02 2011-09-08 Asahi Kasei Pharma Corporation Sulfonamide Compound and Crystal Thereof
TWI619770B (zh) * 2007-11-30 2018-04-01 布勒岡股份有限公司 新穎的矽氧烷聚合物組成物
TW201129557A (en) * 2009-12-29 2011-09-01 Kowa Co Pharmaceutical composition for oral administration
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
WO2011145340A1 (ja) 2010-05-19 2011-11-24 興和株式会社 非アルコール性脂肪性肝炎の予防及び/又は治療剤
US9777028B2 (en) * 2015-06-17 2017-10-03 Gilead Sciences, Inc. Co-crystals, salts and solid forms of tenofovir alafenamide
WO2018092765A1 (ja) * 2016-11-15 2018-05-24 学校法人同志社 経鼻投与用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112152A (en) * 1994-12-26 2000-11-21 Identa Ltd Process and test kit for cocaine detection
ATE285402T1 (de) * 1997-05-26 2005-01-15 Kowa Co Neue zyklische diaminverbindungen und heilmittel das diese enthält
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
AU2003289039A1 (en) * 2002-12-12 2004-06-30 Kowa Co., Ltd. Hydroxyalkylated cyclic diamine compound
MY140849A (en) * 2003-07-07 2010-01-29 Kowa Co 2, 4-bis (trifluoroethoxy) pyridine compound and drug containing the compound

Also Published As

Publication number Publication date
US20060079688A1 (en) 2006-04-13
JP2010235635A (ja) 2010-10-21
US7750150B2 (en) 2010-07-06
US20100234599A1 (en) 2010-09-16
MY140618A (en) 2009-12-31
JP4594863B2 (ja) 2010-12-08
CN102702171B (zh) 2014-09-10
CN1753886B (zh) 2012-07-18
BRPI0407908A (pt) 2006-02-14
PL378292A1 (pl) 2006-03-20
KR101106127B1 (ko) 2012-01-20
ATE554083T1 (de) 2012-05-15
CN1753886A (zh) 2006-03-29
TW201202218A (en) 2012-01-16
TW200504052A (en) 2005-02-01
CN102702171A (zh) 2012-10-03
US8518936B2 (en) 2013-08-27
AU2004215523A1 (en) 2004-09-10
EA200501379A1 (ru) 2006-02-24
TWI355384B (en) 2012-01-01
NO331272B1 (no) 2011-11-14
JPWO2004076441A1 (ja) 2006-06-01
KR20050105218A (ko) 2005-11-03
JP5180998B2 (ja) 2013-04-10
EP1598346B1 (en) 2012-04-18
CA2516822A1 (en) 2004-09-10
IL170093A (en) 2012-02-29
EA009045B1 (ru) 2007-10-26
IS7978A (is) 2005-08-12
MXPA05009129A (es) 2005-10-20
NO20054100L (no) 2005-09-22
ES2384517T3 (es) 2012-07-06
AU2004215523B2 (en) 2009-07-16
DK1598346T3 (da) 2012-05-29
EP1598346A4 (en) 2007-08-15
CA2516822C (en) 2012-09-25
NZ541716A (en) 2007-11-30
EP1598346A1 (en) 2005-11-23
WO2004076441A1 (ja) 2004-09-10
TWI374136B (en) 2012-10-11

Similar Documents

Publication Publication Date Title
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
DE602004024545D1 (de) Indungen
NO20054100D0 (no) Fremgangsmate for fremstilling av syreaddisjonssalter
PL1781683T3 (pl) Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich
EA200970569A1 (ru) Применимые в качестве гербицидных соединений пиридопиразиновые производные
ATE420875T1 (de) Verfahren zur herstellung von 5-(4-ä4-(5-cyano-3- indolyl)-butylü-1-piperazinyl)-benzofuran-2- carboxamid
ATE498617T1 (de) Verfahren zur herstellung einer 3-o- alkylascorbinsäure
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
ATE459617T1 (de) Verfahren zur herstellung von pyridinmethylsulphinylverbindungen
ATE419230T1 (de) Verfahren zur herstellung von 2,6-dihalo-para- trifluoromethylanilin
CY1111994T1 (el) Νεα μεθοδος για την παρασκευη σουλφονυλπυρρολιων ως αναστολεις hdac
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
TW200700370A (en) Producing method of haloalkylether compounds
BRPI0409644A (pt) processo para a preparação de nicotinaldeìdos
TW200621691A (en) Chiral 3-halophthalic acid derivatives
TW200712054A (en) Method for producing 2,3-dihydropyridazine compound
FR2869905B1 (fr) Procede de preparation d'ester de l'acide 1,5-diphenylpyrazole carboxylique.
RU2018123595A (ru) Способ получения хелатообразующего агента
RU2004102604A (ru) Способ кристаллизации азитромицина дигидрата
TH60894A (th) วิธีการสำหรับการเตรียมแอสซิทาโลแพรม
TH84983A (no)
TH85269A (no)
TH110856A (th) กรรมวิธีเชิงเคมี
DE60108242D1 (de) Herstellung von hydroxyverbindungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees